HYTN Secures Health Canada Drug Licence to Propel Cannabinoid Prescription Drug Pathway
LOS ANGELES- Vancouver-based HYTN Innovations Inc. (CSE: HYTN; OTC Pink: HYTNF) announced on ...
HCN News Team2025-07-16T02:36:12-08:00July 16th, 2025|Capital, Insights, International|
LOS ANGELES- Vancouver-based HYTN Innovations Inc. (CSE: HYTN; OTC Pink: HYTNF) announced on ...
HCN News Team2025-07-08T06:38:31-08:00July 8th, 2025|Business, Insights, International, Online|
LOS ANGELES- Brazil’s health-tech startup Blis says its mobile platform ...
HCN News Team2025-07-09T05:26:30-08:00July 9th, 2025|Brands, Business, International, International Insights, Markets, News|
LOS ANGELES - In a major development out of the ...
Subscribe To Highly Capitalized’s Newsletter
DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more
© Copyright | Highly Capitalized | All Rights Reserved | Website by Vadimages.